I read the PR's now and a year ago when I had a position in ctix what I don't get is the statement
Less than two years ago, PolyMedix had 28 employees, a market capitalization of $227.4 million and was rated as “outperform” by a well-known investment banking firm.
If polymedix was an outperformer and B was a game changing drug how does polmedix go bankrupt? Ok say bad management then why what seems to be only one suitor in buying the 9 pipeline compounds?